Forskning
Udskriv Udskriv
Switch language
  1. Rigshospitalet
  2. Publikationer
  3. The majority of newly diagnosed myeloma ...
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

The majority of newly diagnosed myeloma patients do not fulfill the inclusion criteria in clinical phase III trials

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

DOI

Fra samme tidsskrift

  1. Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia

    Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  2. Epidemiology of bloodstream infections in patients with chronic lymphocytic leukemia: a longitudinal nation-wide cohort study

    Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  3. Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia

    Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  4. NT5C2 germline variants alter thiopurine metabolism and are associated with acquired NT5C2 relapse mutations in childhood acute lymphoblastic leukaemia

    Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  5. Evolution of relative survival for acute promyelocytic leukemia patients alive at landmark time-points: a population-based study

    Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Med samme forfattere

  1. Genetic polymorphisms in genes of class switch recombination and multiple myeloma risk and survival: an IMMEnSE study

    Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  2. Clarithromycin added to bortezomib-cyclophosphamide-dexamethasone impairs health-related quality of life in multiple myeloma patients

    Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  3. Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression: a prospective, open-label, multicenter, randomized, phase 3 study

    Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  4. Risk factors for infections in newly diagnosed Multiple Myeloma patients: A Danish retrospective nationwide cohort study

    Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  5. Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients

    Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Vis graf over relationer
OriginalsprogEngelsk
TidsskriftLeukemia
Vol/bind33
Sider (fra-til)546-549
Antal sider5
ISSN0887-6924
DOI
StatusUdgivet - 2019

ID: 55722428